Blood Transfusion Autologous
📧 Sign up to get email alerts when something new happens for Blood Transfusion Autologous.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-04EMA Authorised: Silapo (epoetin zeta) — Stada Arzneimittel AG
The EMA authorises Silapo (epoetin zeta) by Stada Arzneimittel AG for treating anemia associated with cancer, chronic kidney failure, and bl…
-
EMA approval · 2026-07-03EMA Authorised: NeoRecormon (epoetin beta) — Roche Registration GmbH
NeoRecormon (epoetin beta) has been authorised by the EMA for related indications in chronic kidney failure, anemia, cancer, and autologous …
-
EMA approval · 2020-11-25EMA Authorised: Silapo (epoetin zeta) — Stada Arzneimittel AG
Silapo (epoetin zeta) has been authorised by the EMA for indications related to anemia associated with chronic kidney disease, cancer, and u…